摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7,7-dimethyl-3-[4-(4-methyl-piperazin-1-yl)-2-nitro-benzoylamino]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-2,5-dicarboxylic acid 5-tert-butyl ester 2-ethyl ester | 942468-62-4

中文名称
——
中文别名
——
英文名称
7,7-dimethyl-3-[4-(4-methyl-piperazin-1-yl)-2-nitro-benzoylamino]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-2,5-dicarboxylic acid 5-tert-butyl ester 2-ethyl ester
英文别名
5-O-tert-butyl 2-O-ethyl 7,7-dimethyl-3-[[4-(4-methylpiperazin-1-yl)-2-nitrobenzoyl]amino]-4,6-dihydropyrazolo[4,3-c]pyridine-2,5-dicarboxylate
7,7-dimethyl-3-[4-(4-methyl-piperazin-1-yl)-2-nitro-benzoylamino]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-2,5-dicarboxylic acid 5-tert-butyl ester 2-ethyl ester化学式
CAS
942468-62-4
化学式
C28H39N7O7
mdl
——
分子量
585.66
InChiKey
ZXGDRPSEVUBIPO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    42
  • 可旋转键数:
    7
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    155
  • 氢给体数:
    1
  • 氢受体数:
    10

文献信息

  • Substituted Pyrazolo[4,3-c]Pyridine Derivatives Active as Kinase Inhibitors
    申请人:Bandiera Tiziano
    公开号:US20090023745A1
    公开(公告)日:2009-01-22
    Substituted pyrazolo[4,3-c]pyridine derivatives of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful in therapy in the treatment of diseases associated with a dysregulated protein kinase activity, like cancer.
    本发明公开了式(I)的取代吡唑并[4,3-c]吡啶衍生物及其药学上可接受的盐,其定义在规范中,以及它们的制备方法和包含它们的制药组合物;本发明的化合物可能在治疗与蛋白激酶活性失调相关的疾病,如癌症方面有用。
  • SUBSTITUTED PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS
    申请人:Bandiera Tiziano
    公开号:US20110230470A1
    公开(公告)日:2011-09-22
    Substituted pyrazolo[4,3-c]pyridine derivatives of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful in therapy in the treatment of diseases associated with a dysregulated protein kinase activity, like cancer.
    本发明揭示了式(I)的替代吡唑并[4,3-c]吡啶衍生物及其药学上可接受的盐,如规范中所定义的,以及其制备方法和包含它们的药物组合物;该发明的化合物可能在治疗与异常调节的蛋白激酶活性相关的疾病,如癌症方面有用。
  • US7947686B2
    申请人:——
    公开号:US7947686B2
    公开(公告)日:2011-05-24
  • US8173659B2
    申请人:——
    公开号:US8173659B2
    公开(公告)日:2012-05-08
查看更多